lung volume reduction surgery


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.
Related to lung volume reduction surgery: bullectomy

lung volume reduction surgery

procedure whereby nonfunctional lung tissue in emphysema patients is removed, allowing more room in the thoracic cavity for good relatively healthy tissue and thus theoretically improving lung function.
See also: emphysema.

lung vol·ume re·duc·tion sur·ger·y

(lŭng vol'yūm rĕ-dŭk'shŭn sŭr'jĕr-ē)
Procedure whereby nonfunctional lung tissue in emphysema patients is removed, allowing more room in the thoracic cavity for relatively healthy tissue and thus theoretically improving lung function.
See also: emphysema

lung volume reduction surgery

Surgical removal of emphysematous lung tissue, esp. of inelastic air spaces in the upper lobes of the lungs, to enhance the ability of the rest of the lung to expand and contract. This surgery improves respiratory function for many patients with advanced chronic obstructive lung disease although the long-term benefits of its use are uncertain.
See also: surgery
References in periodicals archive ?
A clinician's guide to the use of lung volume reduction surgery. Proc Am Thorac Soc.
Health-related quality of life improves following pulmonary rehabilitation and lung volume reduction surgery. Chest.
Lung volume reduction surgery followed by only 10 daily sessions of pulmonary rehabilitation may not be sufficient time to see physiological changes in these parameters in these patients.
Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD.
Five years after bilateral lung volume reduction surgery (LVRS), 63% of the patients were still alive.
Other speakers who discussed lung volume reduction surgery at the meeting noted that the procedure is appropriate for only a small percentage of COPD patients.
Lung volume reduction surgery costs about $25,000 per patient.
The interim results of the National Emphysema Treatment Trial report a 30-day 16% postoperative mortality rate in a subset of patients who underwent lung volume reduction surgery and had severe homogeneous lung involvement.